Unbiased News Awaits.
Published loading...Updated

Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Funding

  • Persist AI announced on May 19, 2025, in Sacramento the launch of its Cloud Lab and a $12 million Series A funding round led by Spero Ventures.
  • The company developed its AI-driven platform to address prolonged drug formulation times that traditionally take years, especially for complex products like long-acting injectables.
  • Persist AI combines predictive AI models with automated robotics to allow pharmaceutical clients to remotely design, build, and test hundreds of formulations via its website-based Cloud Lab.
  • In a recent project, Persist AI tested 700 formulations in two months versus the industry average of 10-15 per month, achieving an optimal injectable formulation and using just 1 mL of liquid per test.
  • The $12 million funding will expand robotic labs, improve AI training data, establish GMP manufacturing for injectables, and support collaborations including one with Sacramento-based Nivagen Pharmaceuticals.
Insights by Ground AI
Does this summary seem wrong?

11 Articles

All
Left
Center
3
Right
mammothtimes.commammothtimes.com
+8 Reposted by 8other sources
Center

Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Funding

AI-driven robotics platform reduces drug formulation development time from years to months

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Chandler Arizonan broke the news in Chandler, United States on Monday, May 19, 2025.
Sources are mostly out of (0)